Bronchiectasis Treatment

Bronchiectasis treatment

Individuals Living With Bronchiectasis May Benefit From Stem Cell Treatment

Bronchiectasis treatment is designed to help people manage and live with the effects of this chronic obstructive lung condition. Periodic episodes of breathing difficulties can flare-up as inflammation develops within the airways (bronchi). Over time, this inflammation can cause the walls of the bronchi to thicken and prevent mucus from draining properly. The resulting accumulation of mucus can allow bacteria to build up in the lungs, leading to infections and scarring. Because the inflammation is cyclical, effective bronchiectasis treatment is essential not only for helping an individual breathe easier, but also for preserving respiratory function.

Traditional forms of bronchiectasis treatment include antibiotics and mucus-thinning medications and devices, all of which can vary widely in effectiveness. As an alternative treatment for bronchiectasis, the Lung Institute offers stem cell therapy. This landmark therapy has the potential to improve lung function and promote healing by utilizing the power of a patient’s own stem cells. The most significant characteristic of stem cells is that they are undifferentiated, which means they have the ability to replicate themselves and then become specialized to potentially match any type of cell in the body, such as a healthy lung cell.

The Lung Institute offers two minimally invasive, outpatient stem cell procedures for bronchiectasis treatment:

  • Venous (blood-derived) stem cell therapy ­– Stem cells are derived from a patient’s blood. After drawing a blood specimen, we separate its components in our onsite lab, then intravenously return the concentrated stem cells to the patient’s body.
  • Bone marrow stem cell therapy – Stem cells are harvested from a patient’s bone marrow (a spongy substance that fills the inner cavities of bones where blood is produced). After collecting a small amount of a patient’s bone marrow fluid, we separate the cells in the sample, then intravenously reintroduce the stem cells to the patient’s body.

At the Lung Institute, we understand that many people who are living with chronic lung conditions simply want to be able to perform everyday tasks without feeling tired or becoming breathless. With this in mind, we have pioneered stem cell therapy as an alternative bronchiectasis treatment. As the only stem cell clinic in the world that focuses exclusively on treating lung disease, we continue to lead the way in helping these patients find a better quality of life.

Contact the Lung Institute today at (800) 729-3065 to learn more about our unique stem cell therapies for alternative bronchiectasis treatment.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.